TRPV2 has also been found to be upregulated in various models of muscular dystrophy (MD), a multifaceted disease that is characterized by development of progressive muscle weakness and is commonly associated with development of dilated cardiomyopathy (DCM). This evidence concerns the gene TRPV2 and muscular dystrophy.